抗病毒治疗-话题@MedSci

#抗病毒治疗#

121篇内容 | 5664人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1292848, encodeId=62fd1292848f3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, objectType=article, longId=138064, objectId=bdd0138064e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdd0138064e2, replyNumber=0, likeNumber=72, createdTime=2018-05-15, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdd0138064e2, moduleTitle=Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdd0138064e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292847, encodeId=ce43129284e25, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, objectType=article, longId=137872, objectId=094213e872ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094213e872ba, replyNumber=0, likeNumber=74, createdTime=2018-05-12, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094213e872ba, moduleTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094213e872ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292846, encodeId=597812928466a, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？, objectType=article, longId=136297, objectId=13eb13629ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13eb13629ed7, replyNumber=0, likeNumber=95, createdTime=2018-04-25, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13eb13629ed7, moduleTitle=Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13eb13629ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292845, encodeId=d3291292845f3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件, objectType=article, longId=136264, objectId=b4b31362646f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b31362646f, replyNumber=0, likeNumber=75, createdTime=2018-04-25, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b31362646f, moduleTitle=J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b31362646f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292844, encodeId=9c4c129284471, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素, objectType=article, longId=135788, objectId=2353135e889a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2353135e889a, replyNumber=0, likeNumber=94, createdTime=2018-04-20, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2353135e889a, moduleTitle=J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2353135e889a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292843, encodeId=fecb1292843ae, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低, objectType=article, longId=135179, objectId=35111351e931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35111351e931, replyNumber=0, likeNumber=81, createdTime=2018-04-14, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35111351e931, moduleTitle=J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35111351e931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292842, encodeId=85791292842de, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, objectType=article, longId=135062, objectId=0b8e13506250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b8e13506250, replyNumber=0, likeNumber=83, createdTime=2018-04-13, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b8e13506250, moduleTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b8e13506250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292841, encodeId=aedb129284167, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, objectType=article, longId=134584, objectId=a694134584fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a694134584fd, replyNumber=0, likeNumber=123, createdTime=2018-04-10, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a694134584fd, moduleTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a694134584fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292840, encodeId=92c012928405b, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见, objectType=article, longId=132927, objectId=23e913292e7d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e913292e7d, replyNumber=0, likeNumber=84, createdTime=2018-03-21, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e913292e7d, moduleTitle=J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e913292e7d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292839, encodeId=dc1f1292839e5, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发, objectType=article, longId=132220, objectId=47ea132220d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ea132220d6, replyNumber=0, likeNumber=105, createdTime=2018-03-14, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ea132220d6, moduleTitle=Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47ea132220d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292838, encodeId=7f5f129283835, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果, objectType=article, longId=132041, objectId=b1db13204187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1db13204187, replyNumber=0, likeNumber=91, createdTime=2018-03-12, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1db13204187, moduleTitle=South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1db13204187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292837, encodeId=4d52129283e6f, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Circ J：HCV抗病毒治疗减少了心力衰竭等心血管事件的发生, objectType=article, longId=131796, objectId=f6ac131e9671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6ac131e9671, replyNumber=0, likeNumber=123, createdTime=2018-03-09, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6ac131e9671, moduleTitle=Circ J：HCV抗病毒治疗减少了心力衰竭等心血管事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6ac131e9671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292836, encodeId=452a12928363e, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, objectType=article, longId=127902, objectId=f5aa12e90269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5aa12e90269, replyNumber=0, likeNumber=91, createdTime=2018-01-28, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5aa12e90269, moduleTitle=J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5aa12e90269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292835, encodeId=1457129283511, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？, objectType=article, longId=127810, objectId=b97612e810f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97612e810f8, replyNumber=0, likeNumber=0, createdTime=2018-01-28, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97612e810f8, moduleTitle=Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97612e810f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292834, encodeId=92f312928340f, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险, objectType=article, longId=127564, objectId=bc6c12e56400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6c12e56400, replyNumber=0, likeNumber=112, createdTime=2018-01-26, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6c12e56400, moduleTitle=Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6c12e56400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292833, encodeId=b9b1129283388, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响, objectType=article, longId=127473, objectId=3cb212e47384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cb212e47384, replyNumber=0, likeNumber=65, createdTime=2018-01-25, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cb212e47384, moduleTitle=J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cb212e47384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292832, encodeId=84951292832d3, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局, objectType=article, longId=125810, objectId=ac0d125810f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0d125810f4, replyNumber=0, likeNumber=73, createdTime=2018-01-08, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0d125810f4, moduleTitle=J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac0d125810f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292831, encodeId=63bd12928315e, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标, objectType=article, longId=122583, objectId=10dc122583e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10dc122583e8, replyNumber=0, likeNumber=91, createdTime=2017-12-08, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10dc122583e8, moduleTitle=J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10dc122583e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292830, encodeId=46f91292830ec, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大, objectType=article, longId=122445, objectId=ee5c12244584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5c12244584, replyNumber=0, likeNumber=86, createdTime=2017-12-07, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5c12244584, moduleTitle=J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5c12244584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1292829, encodeId=d268129282959, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a>, objectTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, objectType=article, longId=122123, objectId=30d7122123c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30d7122123c6, replyNumber=0, likeNumber=86, createdTime=2017-12-04, rootId=0, userName=dangious, userId=1ce4238, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30d7122123c6, moduleTitle=J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30d7122123c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗病毒治疗

2020-05-29

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Liver Int：HCV患者在接受直接抗病毒治疗过程中，HBV再激活的风险

2018-05-15

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较

2018-05-12

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Radiology：抗病毒治疗在延缓慢性乙肝肝硬化进展的作用有多大呢？

2018-04-25

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：HepCom评分，在启动直接抗病毒治疗后，可以检测出高危人群以及相关的临床事件

2018-04-25

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Infect Dis：我国学者揭示人感染H7N9禽流感病毒排毒时间的独立危险因素：延迟抗病毒治疗和应用糖皮质激素

2018-04-20

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Gastroenterol Hepatol：sCD163和sMR与CHB患者的组织学炎症活动度和纤维化有关；抗病毒治疗后，两者水平均降低

2018-04-14

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略

2018-04-13

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子

2018-04-10

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Viral Hepat：HCV患者接受直接抗病毒治疗获得SVR后，肝脏测试的持续变化并不少见

2018-03-21

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Ann Surg：在血清HBV DNA载量较低的患者中，抗病毒治疗减少了肝细胞癌复发

2018-03-14

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

South Med J：先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果

2018-03-12

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Circ J：HCV抗病毒治疗减少了心力衰竭等心血管事件的发生

2018-03-09

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：CHC患者发生慢性肾脏疾病的风险更高，血液透析患者抗病毒治疗后生存获益

2018-01-28

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Lancet Infect Dis：流感：奥司他韦联合抗病毒治疗比单药临床获益更多？

2018-01-28

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

Lancet Gastroen Hepatol：HCV抗病毒治疗过程中的HBV再激活风险

2018-01-26

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Gastroenterol Hepatol：乙肝表面抗原的整合对抗病毒治疗患者HBsAg水平的影响

2018-01-25

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Hepatol：等待肝移植期间接受抗病毒治疗的患者的临床结局

2018-01-08

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Cell Mol Med：肝组织免疫组织化学检测HBcAg(-)是抗病毒治疗的预测指标

2017-12-08

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Viral Hepat：肝炎暴发的患者，在抗病毒治疗早期HBsAg快速下降且下降幅度较大

2017-12-07

dangious (审核中...)

前往app查看评论内容

#抗病毒治疗#

J Viral Hepat：HBeAg(+)高病毒载量患者，抗病毒治疗期间病毒抑制延迟增加了HCC发生率

2017-12-04

科室
- - 订阅+
  - 更多科室
工具
服务